Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat he...
To pick up a draggable item, press the space bar.
While dragging, use the arrow keys to move the item.
Press space again to drop the item in its new position, or press escape to cancel.
Peer Benchmarks
Quote
Value
Size
Growth
Profit
ONCO
Peers
Sector
Market Cap
440.2 M
164.9 M
600.7 M
Price % of 52 Week High
39.1%
44.2%
58.9%
Dividend Yield
0.0%
0.0%
0.0%
Shareholder Yield
-71.8%
-23.1%
-0.7%
1 Year Price Total Return
-44.8%
-34.5%
-15.8%
Beta (5 Year)
-0.54
0.91
0.64
In the News
No data available
Fair Value
Average
2.04
Upside
4.4%
Uncertainty
HIGH
Spread
0.84 - 2.57
Market Range
52 weeks
kr1
kr5
kr1.95
Analyst Targets
3 analysts
kr2
kr4
kr2.50
Investing Models
kr1
kr3
kr2.04
Financial Health
Financial Health for Oncopeptides is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.
Press space bar to start a drag.
When dragging you can use the arrow keys to move the item around and escape to cancel.
Some screen readers may require you to be in focus mode or to use your pass through key